Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) – Sanofi EFC17236 MOBILIZE
If CIDP Is Affecting Your Life, This Study May Be an Option for You
The Las Vegas Neurology Center along with Profound Research are enrolling a Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) study that is assessing an investigational medication to see if it helps improve functional disability.
To be eligible to participate, you must:
- Be at least 18 years of age
- Be diagnosed or possibly have CIDP
- Be non-responsive to immunoglobulin or corticosteroid therapy
- Have an INCAT score of 2-9
- Not have Guillain-Barré syndrome or diabetic neuropathy
Additional criteria apply.
Qualified participants will receive:
- Study-related care and study medication at no cost
- Financial compensation for time and travel expenses
Number of visits and duration of study:
- 17 clinic visits over 42 weeks and 5 additional phone call visits
Call us at 725-226-5989 or complete the form and our team will reach out soon to help determine your eligibility.